(Q37832117)

24 August 2017

1 reference

title

Thyroid cancer in 2010: a roadmap for targeted therapies (English)

1 reference

24 August 2017

1 reference

Francesca Carlomagno

1

1 reference

24 August 2017

Massimo Santoro

series ordinal

2

1 reference

24 August 2017

publication date

1 February 2011

1 reference

Nature Reviews Endocrinology

24 August 2017

published in

1 reference

24 August 2017

volume

7

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

65-67

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2010.232

24 August 2017

exact match

0 references

cites work

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.232

Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.232

Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.232

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.232

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.232

Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.232

Tumorigenic and metastatic activity of human thyroid cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.232

DNA breaks at fragile sites generate oncogenic RET/PTC rearrangements in human thyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.232

Role of H2O2 in RET/PTC1 chromosomal rearrangement produced by ionizing radiation in human thyroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.232

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2010.232

31 March 2020

Identifiers

DOI

10.1038/NRENDO.2010.232

1 reference

Dimensions Publication ID

24 August 2017

1004283076

0 references

1 reference